News & Perspective

Sep 19, 2003

Sep 19, 2003

Potential treatment for HUS fails in major clinical trial

(CIDRAP News) – A drug that researchers hoped would offer the first effective treatment for hemolytic uremic syndrome (HUS)—a sometimes fatal kidney condition that can result from eating food contaminated with Escherichia coli O157:H7—has proved ineffective in a major clinical trial.